Education
About Us
Working with TipRanks
Follow Us
Omnicell (OMCL)
:OMCL
OMCL Stock Chart & Stats
Day’s Range― - ―
52-Week Range$22.66 - $55.75
Previous CloseN/A
Volume97.52K
Average Volume (3M)526.58K
Market Cap
$1.43B
Enterprise Value$1.33B
Total Cash (Recent Filing)$399.00M
Total Debt (Recent Filing)$372.56M
Price to Earnings (P/E)63.2
Beta0.29
Next Earnings
Nov 04, 2025EPS Estimate
0.36Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.45
Shares Outstanding45,934,250
10 Day Avg. Volume444,817
30 Day Avg. Volume526,575
Financial Highlights & Ratios
PEG Ratio-1.02
Price to Book (P/B)1.65
Price to Sales (P/S)1.84
P/FCF Ratio13.55
Enterprise Value/Market Cap0.93
Enterprise Value/Revenue1.16
Enterprise Value/Gross Profit2.65
Enterprise Value/Ebitda14.23
Forecast
1Y Price Target
$41.75Price Target Upside31.29% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering6
Bulls Say, Bears Say
Bulls Say
Business StrategyManagement has high visibility into future performance with a range of 95% to 100%, suggesting confidence in meeting or exceeding expectations.
Financial PerformanceThe company achieved higher-than-expected revenue and adjusted EBITDA, surpassing guidance and consensus estimates.
Tariff ConditionsA potential post-pause tariff rate of 55% implies a favorable scenario for Omnicell, leading to significant savings.
Bears Say
Revenue Growth UncertaintyLimited visibility into components of product revenue growth creates uncertainty near-term.
Tariff And Legislation ImpactThe broader CapEx outlook weakened for the second consecutive quarter as uncertainty around tariffs and legislation appear to be impacting spend.
Omnicell News
OMCL FAQ
What was Omnicell’s price range in the past 12 months?
Omnicell lowest stock price was $22.66 and its highest was $55.74 in the past 12 months.
What is Omnicell’s market cap?
Omnicell’s market cap is $1.43B.
When is Omnicell’s upcoming earnings report date?
Omnicell’s upcoming earnings report date is Nov 04, 2025 which is in 46 days.
How were Omnicell’s earnings last quarter?
Omnicell released its earnings results on Jul 31, 2025. The company reported $0.45 earnings per share for the quarter, beating the consensus estimate of $0.27 by $0.18.
Is Omnicell overvalued?
According to Wall Street analysts Omnicell’s price is currently Undervalued.
Does Omnicell pay dividends?
Omnicell does not currently pay dividends.
What is Omnicell’s EPS estimate?
Omnicell’s EPS estimate is 0.36.
How many shares outstanding does Omnicell have?
Omnicell has 45,934,250 shares outstanding.
What happened to Omnicell’s price movement after its last earnings report?
Omnicell reported an EPS of $0.45 in its last earnings report, beating expectations of $0.27. Following the earnings report the stock price went up 4.411%.
Which hedge fund is a major shareholder of Omnicell?
Currently, no hedge funds are holding shares in OMCL
Omnicell Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$41.75 (31.29% Upside)
$41.75 (31.29% Upside)
Blogger Sentiment
Bullish
OMCL Sentiment 70%
Sector Average 73%
Sector Average 73%
Hedge Fund Trend
Decreased
By 50.1K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 3.3%
Last 30 Days ▼ 3.6%
Last 30 Days ▼ 3.6%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-30.58%
12-Months-Change
Fundamentals
Return on Equity
1.87%
Trailing 12-Months
Asset Growth
-6.38%
Trailing 12-Months
Company Description
Omnicell
Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; Omnicell Interface Software that offers interface and integration between its medication-use products or supply products, and a healthcare facility's in-house information management systems; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions, including automated storage and retrieval systems, such as XR2 Automated Central Pharmacy System; IV compounding robots and workflow management systems; inventory management software; and controlled substance management systems. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based nexus of solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Mountain View, California.
OMCL Company Deck
OMCL Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call reflected a positive outlook with strong revenue growth, increased earnings per share, successful product launches, and significant customer wins. However, challenges like tariff impacts and increased inventory levels were noted. Overall, the highlights outweigh the lowlights, indicating a positive sentiment.View all OMCL earnings summariesOMCL Stock 12 Month Forecast
Average Price Target
$41.75
▲(31.29% Upside)
Technical Analysis
Ownership Overview
2.94% Insiders
29.86% Mutual Funds
14.93% Other Institutional Investors
19.40% Public Companies and
Individual Investors